Orexa
Company Details
Status: Private
Employees: 1-10
Location:
Berghemseweg 8, Herpen, The Netherlands
Type:
sample
Technology:
sample
About: Orexa is a phase 2 pharmaceutical company that develops and commercializes therapeutics to increase food intake. Its lead compound ORE-001 is a proprietary oral formulation, based on a well known anesthetic. The company has started its first phase 2a study in the Prevention of Post-Operative Ileus.
Furthermore it is in preparation for phase 2a studies in Anorexia and Cachexia. With these three indications increased food intake could lead to an improved patient health, a shorter hospital stay and significant cost savings. Orexa was founded in 2016 and is headquartered in Herpen (Oss Region, Noord Brabant), The Netherlands.
Attractive risk/reward:
• Lower risk, because the active substance is already well known for many decades;
• Lean and fast development plan;
• Very attractive market potential.
Strong patent portfolio:
• Broad claims for all local anesthetics to increase food intake after both single and repeated administration;
• Well understood mode of action;
• Novel mode of delivery, with a proprietary oral formulation.
We are looking for partnerships with:
★ an experienced mid or big pharma company with a focus on 505(b)(2) applications for the late stage clinical development and for the marketing in the US & EU markets (and possibly more);
★ a suitable Chinese company with experience in phase 2 & phase 3 clinical trials and an effective sales channel in the majority of the Chinese market;
★ a large scale specialized animal food company or a large veterinary drug company for the veterinary applications.
We’d love to hear from you. We’ll get back to you as soon as we can!
You can contact us at info@orexa.nl.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Orexa | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.